Laboratory Corporation of... (LH)
Laboratory of America Statistics
Share Statistics
Laboratory of America has 83.7M shares outstanding. The number of shares has increased by -0.55% in one year.
Shares Outstanding | 83.7M |
Shares Change (YoY) | -0.55% |
Shares Change (QoQ) | -0.39% |
Owned by Institutions (%) | 0.11% |
Shares Floating | 83.4M |
Failed to Deliver (FTD) Shares | 4.25K |
FTD / Avg. Volume | 0.69% |
Short Selling Information
The latest short interest is 2.01M, so 2.41% of the outstanding shares have been sold short.
Short Interest | 2.01M |
Short % of Shares Out | 2.41% |
Short % of Float | 2.42% |
Short Ratio (days to cover) | 3.9 |
Valuation Ratios
The PE ratio is 25.7 and the forward PE ratio is 15.56. Laboratory of America's PEG ratio is 0.3.
PE Ratio | 25.7 |
Forward PE | 15.56 |
PS Ratio | 1.47 |
Forward PS | 1.6 |
PB Ratio | 2.38 |
P/FCF Ratio | 17.49 |
PEG Ratio | 0.3 |
Enterprise Valuation
Laboratory Corporation of America has an Enterprise Value (EV) of 25.21B.
EV / Earnings | 33.8 |
EV / Sales | 1.94 |
EV / EBITDA | 13.92 |
EV / EBIT | 22.8 |
EV / FCF | 23.01 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.9.
Current Ratio | 1.44 |
Quick Ratio | 1.3 |
Debt / Equity | 0.9 |
Total Debt / Capitalization | 47.46 |
Cash Flow / Debt | 0.22 |
Interest Coverage | 5.31 |
Financial Efficiency
Return on equity (ROE) is 0.09% and return on capital (ROIC) is 5.61%.
Return on Equity (ROE) | 0.09% |
Return on Assets (ROA) | 0.04% |
Return on Capital (ROIC) | 5.61% |
Revenue Per Employee | $213,610.84 |
Profits Per Employee | $12,249.59 |
Employee Count | 60,900 |
Asset Turnover | 0.71 |
Inventory Turnover | 19.28 |
Taxes
Income Tax | 212.4M |
Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by 6.02% in the last 52 weeks. The beta is 1.11, so Laboratory of America's price volatility has been higher than the market average.
Beta | 1.11 |
52-Week Price Change | 6.02% |
50-Day Moving Average | 244.8 |
200-Day Moving Average | 228.4 |
Relative Strength Index (RSI) | 33.33 |
Average Volume (20 Days) | 611.46K |
Income Statement
In the last 12 months, Laboratory of America had revenue of 13.01B and earned 746M in profits. Earnings per share was 8.92.
Revenue | 13.01B |
Gross Profit | 3.5B |
Operating Income | 1.11B |
Net Income | 746M |
EBITDA | 1.81B |
EBIT | 1.11B |
Earnings Per Share (EPS) | 8.92 |
Balance Sheet
The company has 1.52B in cash and 7.27B in debt, giving a net cash position of -5.75B.
Cash & Cash Equivalents | 1.52B |
Total Debt | 7.27B |
Net Cash | -5.75B |
Retained Earnings | 8.3B |
Total Assets | 18.38B |
Working Capital | 1.48B |
Cash Flow
In the last 12 months, operating cash flow was 1.59B and capital expenditures -489.9M, giving a free cash flow of 1.1B.
Operating Cash Flow | 1.59B |
Capital Expenditures | -489.9M |
Free Cash Flow | 1.1B |
FCF Per Share | 13.11 |
Margins
Gross margin is 26.92%, with operating and profit margins of 8.5% and 5.73%.
Gross Margin | 26.92% |
Operating Margin | 8.5% |
Pretax Margin | 7.38% |
Profit Margin | 5.73% |
EBITDA Margin | 13.92% |
EBIT Margin | 8.5% |
FCF Margin | 8.42% |
Dividends & Yields
LH pays an annual dividend of $2.88, which amounts to a dividend yield of 1.16%.
Dividend Per Share | $2.88 |
Dividend Yield | 1.16% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 32.58% |
Earnings Yield | 3.85% |
FCF Yield | 5.65% |
Analyst Forecast
The average price target for LH is $265, which is 14.4% higher than the current price. The consensus rating is "Buy".
Price Target | $265 |
Price Target Difference | 14.4% |
Analyst Consensus | Buy |
Analyst Count | 16 |
Stock Splits
The last stock split was on Jul 3, 2023. It was a forward split with a ratio of 291:250.
Last Split Date | Jul 3, 2023 |
Split Type | forward |
Split Ratio | 291:250 |
Scores
Altman Z-Score | 2.78 |
Piotroski F-Score | 9 |